3449 results

Spotlight on major Late-Breaking Trials presented at EuroPCR 2025

21 May 2025

These trials were selected because of their design, results, and potential to impact practice: Discover the key findings of the 4D-ACS and FAITAVI randomised clinical trials and a meta-analysis of PROTECTED TAVR and BHF PROTECT TAVI.

PCR Gulf Valves: Core Team

Introducing the Steering Board Members behind PCR Gulf Valves taking place on 29-30 September 2025!

Late-Breaking Trials and Hotlines: where the latest data is tackled

Be there for the unveiling of pivotal new results and real-world data in structural heart disease. The Heart Team Course brings together the world’s experts for interactive sessions that go beyond results - exploring the insights that drive better patient care.

Visa and letter invitation

In this section you will find all the information regarding the PCR Tokyo Valves 2025 visa and invitation letter

Start strong with PCR Fundamentals Course

If you are a young practitioner or an early beginner in your career, discover a course tailored specifically for you! Choose your track Mitral, Aortic or Tricuspid today for PCR Fundamentals Course!

GulfPCR-GIM - Relive the Best of the Course

From opening to closing, explore the best of #GulfPCR. Watch videos, discover key figures, access replays & your certificates, and more to keep on learning!

Are you an EAPCI Member?

Discover the steps to follow when you register for EuroPCR 2024

The Core Team shaping #PCRLV

Seven experienced Course Directors are working together to make this edition of PCR London Valves the best yet! Their objectif: serve the needs of the entire Heart Team.

Training Village Programme

Transform knowledge into action with 3 rooms dedicated to TAVI, Mitral and Imaging. You’ll gain hands-on experience and simulator training in real-world scenarios, using the latest devices and technology.

Key updates in valvular heart disease management: insights from the 2025 ESC/EACTS Guidelines

03 Sep 2025

Alex Sticchi provides his take on the new ESC Valvular Guidelines presented at the ESC Congress 2025 in Madrid.

Author

Alessandro Sticchi

EuroPCR 2025 – Meta-Analysis of Individual Patient Data from the PROTECTED TAVR and BHF PROTECT-TAVI Trials

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among which is the...

2025 Andreas Grüntzig Ethica Award presented to Lars Wallentin and Stefan James on behalf of Swedish cardiovascular registry experts

20 May 2025

The Andreas Grüntzig Ethica Award is traditionally given to those who have contributed in an extraordinary way to the PCR mission, that of serving the needs of patients by sharing knowledge, experience and practice in cardiovascular interventional medicine.

Spotlight on a selection of top Late-breaking Trials presented at PCR London Valves 2025

17 Nov 2025

View a snapshot of the results of these 4 trials in valvular and structural interventions presented in London during this year's Heart Team Course!

The top ten impactful papers from 2025 on tricuspid intervention we almost missed

13 Jan 2026

Transcatheter interventions have rapidly reshaped the management of tricuspid valve disease, with landmark trials establishing feasibility and early clinical benefit.

Beyond these pivotal studies, a series of less visible but highly informative papers addressed mechanisms, complications, patient phenotypes, and unintended consequences of intervention.

This curated selection highlights ten impactful tricuspid...

Author

Alessandro Sticchi

Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025

21 May 2025

International Women's Day 2025: Raising awareness of aortic stenosis in women: - a silent killer

08 Mar 2025

It was a day in October last year when I had a meeting with patients’ group in UK. At the time, I needed to discuss with them why a registry on valvular heart disease and sex disparities is needed. The camaraderie was incredible and the discussion...

Author

Julia Grapsa

Secure your grant for PCR London Valves

Are you attending the PCR Fundamentals Course? Apply for an Indirect Industry Supported Grant and get your #PCRLV registration fees covered! Limited grants available, and allocated on a first come first served basis!

EuroPCR 2025 – The FAITAVI trial: angiography versus physiology-guided PCI in patients undergoing TAVI – 12-month follow-up data

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

EuroPCR 2025 – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial

21 May 2025

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Major EuroPCR 2025 LBT - 4D-ACS: one-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in acute coronary syndrome

21 May 2025 – From EuroPCR 2025

In this EuroPCR 2025 interview, Davide Capodanno and Woong Chol Kang discuss antithrombotic therapy in patients with acute coronary syndromes, focusing on the design and outcomes of the 4D-ACS trial. They describe the patient population enrolled in the study and introduce the two de-escalation strategies investigated:...